Erbis, Gabriele
Schmidt, Kirstin
Hansmann, Sandra
Sergiichuk, Tetiana
Michler, Christine
Kuemmerle-Deschner, Jasmin B.
Benseler, Susanne M. http://orcid.org/0000-0001-5756-3638
Funding for this research was provided by:
Novartis Pharma (MACZ885A_FVMH007)
Article History
Received: 1 September 2018
Accepted: 12 December 2018
First Online: 20 December 2018
Ethics approval and consent to participate
: The study was approved by the Institutional Research Ethics Board (No. 079-2015BO2). All participating study subjects gave written informed consent or assent as appropriate.
: Not applicable
: G.E. and K.S. were partially funded through the Margarete-Mueller Bull Stiftung and a research grant of Novartis Pharma. G.E. also received speaker honoraria from Novartis Pharma. C.M. was partially funded through a center grant of Novartis Pharma. S.H. received honoraria from Novartis Pharma for Advisory Board attendance. S.B. received speaker honoraria from Novartis and SOBI. J.B.K.-D. performed clinical studies with and received educational, research and center grants and honoraria from Novartis and SOBI. T.S. did not receive any funding for this work. All authors declare no conflict of interest for the published work.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.